Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
-
65180
- 01
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Galderma SA - Mirvaso 3.3mg/g, Gel
Swissmedic Registration
65180
Sequence
01
Product name
Mirvaso 3.3mg/g
Description
Gel
ATC-Classification
D11AX21
ATC-Description
Brimonidine
Introduction of Sequence
21.11.2014
Composition
Gel: brimonidini tartras 5 mg corresp. brimonidinum 3.3 mg, carbomerum, E 218 1 mg, phenoxyethanolum, glycerolum, E 171, propylenglycolum 55 mg, natrii hydroxidum ad pH, aqua purificata, ad gelatum pro 1 g.
Packungsbestandteile
Galenic Form
Gel
Active Agent
Dose
additional_information
Brimonidine Tartrate
5 mg correspond Brimonidine 3.3 mg
Gel
BAG: Active Agent
Dose
Brimonidine
3.3 mg
Inactive agents
Dose
additional_information
1 g
Aqua Purificata
Carbomer
color.
1 mg
conserv.
Glycerol
Phenoxyethanol
Propylenglycol
55 mg
Package number
Package Size
EFP
CP
Category
SL
Out of trade (MedRef)
002
30 g
37.44
57.15
B
SL
No
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
